Techsomed develops AI-powered software solutions for image-guided therapy, specifically focusing on tumor ablation management for cancer treatments. Its flagship BioTrace platform equips physicians with advanced visualization, real-time margin assessment, and tissue response prediction tools to enhance minimally invasive procedures.
Subscribe to see Techsomed’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Techsomed is a medical devices company headquartered in Israel. Xcout tracks 12 named people at Techsomed, including Yossi Abu (CEO).
6 more named people on record for Techsomed, with roles, board committees and tenure — see the full roster →
A few of Techsomed's closest competitors — see the full list of competitors and alternatives →
Current Surgical Inc. is developing a digital surgery platform that combines real-time imaging, focused ultrasound, and AI-driven algorithms to provide millimeter-level precision for treating solid tumors and other medical conditions. The platform aims to assist surgeons by enhancing accuracy and reducing risk in minimally invasive procedures across multiple markets such as oncology, cardiology, and neurology.
Berman Medical is a medical technology company developing an aesthetics and dermatology platform focused on facial injections. Their system combines advanced imaging, spatial tracking, and artificial intelligence to provide clinicians with real-time, patient-specific anatomical navigation during treatments.
DART Imaging is a digital health company specializing in the development of digital breast tomosynthesis technologies and medical imaging solutions.
Clear Guide Medical, Inc. is a privately held medical device company headquartered in Baltimore, Maryland, that develops image-guided technologies utilizing artificial intelligence and augmented reality.
Synaptive Medical Inc. is a Toronto-based global medical device and technology company founded in 2012. The firm develops advanced surgical tools, imaging systems, and informatics to improve clinical outcomes.
Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People's Republic of China and Hong Kong. The company offers products, such as percutaneous puncture surgery robots, includes TH-S1, TH-S, TH-S Pro and TH-SA; microwave ablation surgical robot for the treatment of liver and lung tumors; percutaneous microwave ablation surgical robot TH-X HMW approved for the treatment of liver tumors; AI-based 3D reconstruction software for medical imaging; and five additional product, including the TH-P series of compact percutaneous puncture surgical robots which are approved for lung and abdominal puncture, the MW150 microwave ablation device, the TH-X Cryo cryoablation robot, the TH-LS KI300 and TH-LS LU100 ex vivo organ preservation and assessment systems. The company was formerly known as True Health (Guangdong Hengqin) Medical Technology Co., Ltd. and changed its name to Guangdong True Health Medical Technology Development Co., Ltd. in October 2025. The company was incorporated in 2018 and is based in Zhuhai, China.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.